164 related articles for article (PubMed ID: 25371063)
21. Expression of thymidylate synthase in cancer of the ampulla of Vater.
Ajiki T; Habara K; Kamigaki T; Nakamura T; Fujino Y; Suzuki Y; Takeyama Y; Kuroda Y; Nakamura T
Oncol Rep; 2001; 8(4):759-62. PubMed ID: 11410778
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Impact of Intra-Ampullary Papillary-Tubular Neoplasm versus Flat Dysplasia as Precursor Lesions of Ampullary Adenocarcinoma.
Han S; Jang KT; Choi DW; Choi SH; Heo JS; Han IW; Park D; Ryu Y
Dig Surg; 2020; 37(6):505-514. PubMed ID: 33080609
[TBL] [Abstract][Full Text] [Related]
23. Lack of CD44 variant 6 expression in advanced extrahepatic bile duct/ampullary carcinoma.
Yokoyama Y; Hiyama E; Murakami Y; Matsuura Y; Yokoyama T
Cancer; 1999 Nov; 86(9):1691-9. PubMed ID: 10547541
[TBL] [Abstract][Full Text] [Related]
24. Promyelocytic leukemia (PML) gene expression is a prognostic factor in ampullary cancer patients.
Vincenzi B; Santini D; Perrone G; Russo A; Adamo V; Rizzo S; Castri F; Antinori A; Alloni R; Crucitti PF; Morini S; Rabitti C; Vecchio FM; Magistrelli P; Coppola R; Tonini G
Ann Oncol; 2009 Jan; 20(1):78-83. PubMed ID: 18689862
[TBL] [Abstract][Full Text] [Related]
25. Expression of MUC1 and MUC2 in ampullary cancer.
Moriya T; Kimura W; Hirai I; Takasu N; Mizutani M
Int J Surg Pathol; 2011 Aug; 19(4):441-7. PubMed ID: 21700631
[TBL] [Abstract][Full Text] [Related]
26. Predictors of long-term survival following resection for ampullary carcinoma: a large retrospective French multicentric study.
Robert PE; Leux C; Ouaissi M; Miguet M; Paye F; Merdrignac A; Delpero JR; Schwarz L; Carrere N; Muscari F; Gayet B; Dussart D; Hamy A; Regenet N
Pancreas; 2014 Jul; 43(5):692-7. PubMed ID: 24713843
[TBL] [Abstract][Full Text] [Related]
27. Hepatocyte nuclear factor (HNF) 4α expression distinguishes ampullary cancer subtypes and prognosis after resection.
Ehehalt F; Rümmele P; Kersting S; Lang-Schwarz C; Rückert F; Hartmann A; Dietmaier W; Terracciano L; Aust DE; Jahnke B; Saeger HD; Pilarsky C; Grützmann R
Ann Surg; 2011 Aug; 254(2):302-10. PubMed ID: 21494118
[TBL] [Abstract][Full Text] [Related]
28. Prognosis of ampullary cancer based on immunohistochemical type and expression of osteopontin.
Zhao XQ; Dong JH; Zhang WZ; Liu Z
Diagn Pathol; 2011 Oct; 6():98. PubMed ID: 21992455
[TBL] [Abstract][Full Text] [Related]
29. Treatment utilization and surgical outcome of ampullary and duodenal adenocarcinoma.
Shaib WL; Sharma R; Brutcher E; Kim S; Maithel SK; Chen Z; Kooby DA; Kauh J; Landry J; El-Rayes BF
J Surg Oncol; 2014 May; 109(6):556-60. PubMed ID: 24338561
[TBL] [Abstract][Full Text] [Related]
30. Tumor-specific Expression of Insulin-like Growth Factor II mRNA-binding Protein 3 Independently Predicts Worse Survival of Patients With Adenocarcinoma of the Ampulla of Vater.
Kim HG; Park MS; Sung JY; Kim YW; Kim HS; Na K
Anticancer Res; 2019 Sep; 39(9):4947-4955. PubMed ID: 31519600
[TBL] [Abstract][Full Text] [Related]
31. Increased number of metastatic lymph nodes in adenocarcinoma of the ampulla of Vater as a prognostic factor: a proposal of new nodal classification.
Kang HJ; Eo SH; Kim SC; Park KM; Lee YJ; Lee SK; Yu E; Cho H; Hong SM
Surgery; 2014 Jan; 155(1):74-84. PubMed ID: 24238122
[TBL] [Abstract][Full Text] [Related]
32. Performance and prognostic utility of the 92-gene assay in the molecular subclassification of ampullary adenocarcinoma.
Overman MJ; Soifer HS; Schueneman AJ; Ensor J; Adsay V; Saka B; Neishaboori N; Wolff RA; Wang H; Schnabel CA; Varadhachary G
BMC Cancer; 2016 Aug; 16(1):668. PubMed ID: 27549176
[TBL] [Abstract][Full Text] [Related]
33. Pathological factors influencing survival of carcinoma of the ampulla of Vater.
Mori K; Ikei S; Yamane T; Yamaguchi Y; Katsumori T; Shibata Y; Arai T
Eur J Surg Oncol; 1990 Jun; 16(3):183-8. PubMed ID: 2347413
[TBL] [Abstract][Full Text] [Related]
34. Improved survival for adenocarcinoma of the ampulla of Vater: fifty-five consecutive resections.
Duffy JP; Hines OJ; Liu JH; Ko CY; Cortina G; Isacoff WH; Nguyen H; Leonardi M; Tompkins RK; Reber HA
Arch Surg; 2003 Sep; 138(9):941-8; discussion 948-50. PubMed ID: 12963649
[TBL] [Abstract][Full Text] [Related]
35. Gene expression profiling identifies markers of ampullary adenocarcinoma.
Van Heek NT; Maitra A; Koopmann J; Fedarko N; Jain A; Rahman A; Iacobuzio-Donahue CA; Adsay V; Ashfaq R; Yeo CJ; Cameron JL; Offerhaus JA; Hruban RH; Berg KD; Goggins M
Cancer Biol Ther; 2004 Jul; 3(7):651-6. PubMed ID: 15136764
[TBL] [Abstract][Full Text] [Related]
36. Pathologic T1 subclassification of ampullary carcinoma with perisphincteric or duodenal submucosal invasion: Is it T1b?
You D; Heo J; Choi S; Choi D; Jang KT
Arch Pathol Lab Med; 2014 Aug; 138(8):1072-6. PubMed ID: 25076296
[TBL] [Abstract][Full Text] [Related]
37. Predictors of recurrence after pancreaticoduodenectomy in ampullary cancer: comparison between non-, early and late recurrence.
Hsu HP; Shan YS; Hsieh YH; Yang TM; Lin PW
J Formos Med Assoc; 2007 Jun; 106(6):432-43. PubMed ID: 17588836
[TBL] [Abstract][Full Text] [Related]
38. Pattern analysis of lymph node metastasis and the prognostic importance of number of metastatic nodes in ampullary adenocarcinoma.
Lee JH; Lee KG; Ha TK; Jun YJ; Paik SS; Park HK; Lee KS
Am Surg; 2011 Mar; 77(3):322-9. PubMed ID: 21375845
[TBL] [Abstract][Full Text] [Related]
39. Influence of site of origin and mucin production on survival in ampullary carcinoma.
Dawson PJ; Connolly MM
Ann Surg; 1989 Aug; 210(2):173-9. PubMed ID: 2757420
[TBL] [Abstract][Full Text] [Related]
40. The pathohistological subtype strongly predicts survival in patients with ampullary carcinoma.
Zimmermann C; Wolk S; Aust DE; Meier F; Saeger HD; Ehehalt F; Weitz J; Welsch T; Distler M
Sci Rep; 2019 Sep; 9(1):12676. PubMed ID: 31481741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
